𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of recurrent disease: randomized trials of monotherapy versus combination chemotherapy

✍ Scribed by A. GONZÁLEZ-MARTÍN; GEICO Group

Book ID
109085405
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
74 KB
Volume
15
Category
Article
ISSN
1048-891X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Burkitt's lymphoma: Randomi
Treatment of Burkitt's lymphoma: Randomized clinical trial of single-agent versus combination chemotherapy
✍ Charles L. M. Olweny; Edward Katongole-Mbidde; Albert Kaddu-Mukasa; Isaac Atine; 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 French ⚖ 374 KB

## Abstract A randomized clinical trial designed to compare the effectiveness of cytoxan (CTX) alone versus a combination consisting of CTX, vincristine (Oncovin) and methotrexate (COM) in the treatment of Burkitt's lymphoma (BL) was carried out. Nineteen patients were selected at random to receive

Outcome of recurrent hepatitis C virus a
Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy
✍ Pinelopi Manousou; Dimitrios Samonakis; Evangelos Cholongitas; David Patch; Jame 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 2 views

Less potent immunosuppression is considered to reduce the severity of hepatitis C virus (HCV) recurrence after liver transplantation. An optimal regimen is unknown. We evaluated tacrolimus monotherapy versus triple therapy in a randomized trial of 103 first transplants for HCV cirrhosis. One hundred

Reply: Outcome of recurrent hepatitis C
Reply: Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy
✍ Dinesh Jothimani; Timothy J. S. Cross 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB 👁 1 views

We read with interest the article by Manousou and colleagues, 1 investigating the impact of tacrolimus monotherapy (MT) versus triple therapy (TT) on recurrent hepatitis C infection after liver transplantation. This study examined hepatic fibrosis progression in patients randomized to tacrolimus MT